Satisfaction study of split doses botulinum toxin with double frequency

You may not qualify if:

• Clients with known allergies or sensitivity to the drug or any components of the study medication;
• Use of any agent that impedes the neuromuscular transmission, or other neuromuscular diseases that could amplify the effects of botulinum toxin type A treatment (e.g. myasthenia gravis, excessive weakness, Eaton-Lambert syndrome, or atrophy of target muscles);
• Previous exposure to botulinum toxin < 6 months before the first treatment;
• Has ever received a permanent filler in the upper face, or has received a temporary filler in the upper face in the last two years;
• Presence of an infection, or any type of skin disease, in the treatment area;
• Presence or history of a malignancy like melanoma in the treated area;
• Grade 4 lines in one or more of the treatment areas expressed by the Merz Aesthetic Scales;
• Marked asymmetry of the crow's feet by 1 point on the Merz Aesthetic Scales;
• Females who are pregnant, planning to get pregnant during the full duration of the study, or breastfeeding.
• Clients with body dysmorphic disorder or related diagnosis in the DSM-V.